Good Morning, Traders!…👋

The S&P 500 closed higher on Tuesday, moving between gains and losses as investors weighed a decline in consumer confidence against a Tesla-led rally in tech stocks.

The Conference Board’s consumer confidence index fell to 92.9, down from a revised 100.1 in the prior month, amidst continued concerns over a slowdown potentially triggered by tariffs.

The PCE price index, the Federal Reserve’s preferred inflation gauge, is due Friday. The print, especially core PCE data, is expected to show inflation above the Fed’s 2% target in February. Additionally, revised data on fourth-quarter GDP will be released on Thursday, while home prices and sales figures will be available on Wednesday.

Investor optimism remains buoyed by hopes that President Donald Trump will show more flexibility with his tariff plans, although markets are still awaiting clarity on how the broader tariff agenda will unfold and its potential impact on the global economy.

Watch today’s pre-market earnings from Dollar Tree $DLTR ( ▲ 2.56% ) , Chewy $CHWY ( ▼ 0.09% ) , and Paychex $PAYX ( ▲ 0.09% ) as they drop key insights to kick off the trading day.

Happening Today

✓ 08:30 AM ET – Durable Goods Orders (MoM) (Feb)

✓ 10:00 AM ET – FOMC Member Kashkari Speaks

✓ 10:30 AM ET – Crude Oil Inventories

✓ 01:00 PM ET – 5-Year Note Auction

PREMARKET SNAPSHOT 📈

​As of March 26, 2025, U.S. stock futures are showing slight declines. Investors are closely monitoring upcoming economic data and potential tariff developments.

SECTOR SNAPSHOT✨

Yesterday markets saw a mixed session with strength in growth-oriented sectors like consumer discretionary, communication services, and tech, while defensive areas lagged. Energy and financials posted modest gains, and industrials held slightly positive. However, health care, real estate, utilities, and consumer staples faced notable pressure, dragging overall breadth into neutral territory.

PreMarket Unusual Volume Stocks

📈 AquaBounty Technologies, Inc. $AQB ( ▲ 4.51% )  is drawing notable pre-market attention with 1.96M shares traded compared to an average of just 2.4K, marking an extraordinary surge of over 82,000%. The stock’s sharp move suggests heightened interest, possibly driven by biotech headlines or retail momentum.

📈 SurgePays, Inc. $SURG ( ▲ 6.73% )  has exploded higher with 9.23M shares traded in the pre-market, far outpacing its average of 34.5K. The stock’s 80% jump is likely attracting momentum traders and could signal fresh developments or sentiment shifts.

📈 Theratechnologies Inc. $THTX ( ▲ 5.36% )  is active with 23.87M shares exchanged pre-market versus an average volume of 1.27M. Up 50%, the move suggests investor excitement—potentially tied to clinical updates or strong earnings chatter.

📈 Beeline Holdings, Inc. $BLNE ( ▲ 9.82% )  is on the radar this morning with 419.91K shares traded, up from its usual 31.5K. The 41% surge hints at a possible catalyst or breakout pattern catching traders’ eyes.

📈 Petros Pharmaceuticals, Inc. $PTPI ( ▼ 9.41% )  is making headlines with a staggering 178.24M shares traded pre-market, dwarfing its average of 47.2M. Up 182%, the explosive volume suggests speculative momentum is driving this biotech name sharply higher.

Premarket Picks

Theratechnologies Inc. (THTX) saw a 50.65% surge in pre-market trading, with its stock price reaching $2.32. This increase follows the FDA's approval of its supplemental Biologics License Application for the F8 formulation of tesamorelin for injection.

SurgePays, Inc. (SURG) experienced a 92.03% jump, bringing its pre-market price to $2.65. The surge came after the company reported strong 2024 financial results and issued a revenue guidance of over $200 million for the next 12 months.

TEN Holdings, Inc. (XHLD) experienced a 12.79% surge, bringing its pre-market price to $1.94. The increase followed the announcement of a new partnership with V-Cube Inc., its controlling shareholder, to introduce conversational artificial intelligence solutions to its service offerings.

Climb Bio Inc. (CLYM) saw an 11.54% rise, bringing its pre-market price to $1.45. The company’s surge was driven by the release of its fourth-quarter and year-end 2024 financial results, along with key business updates.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Summit Therapeutics Inc. $SMMT ( ▲ 3.19% ) 

Analyst Firm: Citi
Upgraded: Neutral to Buy
Price Target: $35
Yesterday's Close: $20.24

Citi analyst Yigal Nochomovitz raised Summit Therapeutics' rating from Neutral to Buy, increasing the price target from $23 to $35. Analysts have set a stock price target for Summit Therapeutics Inc. with a high of $44.00, a median of $33.50, and a low of $30.00. The average target price comes to $35.50. Summit Therapeutics is focused on developing patient-friendly therapies in both the U.S. and the U.K.

2. TotalEnergies SE $TTE ( ▼ 0.12% )  

Analyst Firm: Citi
Upgraded: Neutral to Buy
Price Target: $75.58
Yesterday's Close: $63.52

Citi also upgraded TotalEnergies from Neutral to Buy, setting a price target of $75.58. TotalEnergies SE has a stock price target range with a high of $97.72, a median of $72.00, and a low of $62.00, resulting in an average target price of $73.80. The company is a global leader in the production and marketing of oil, biofuels, natural gas, renewables, and electricity.

3. Range Resources Corporation $RRC ( ▲ 1.32% )  

Analyst Firm: Morgan Stanley
Upgraded: Underweight to Equal Weight
Price Target: $49
Yesterday's Close: $40.14

Morgan Stanley's Devin McDermott raised Range Resources' rating from Underweight to Equal Weight, with a new price target of $49, up from $40. For Range Resources Corporation, analysts predict a stock price target range with a high of $53.00, a median of $42.50, and a low of $33.00. The average target price stands at $42.42. Range Resources is an independent company engaged in the exploration and production of natural gas, NGLs, and oil across the U.S.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.